|
|
||||||||
1Department of Nephrology and the 2Wallenberg Laboratory for Cardiovascular Research, Matrix and Proteoglycan Group, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
Submitted 1 June 2004 ; accepted in final form 30 November 2004
This article describes the possible role of the endothelial cell-surface coat, containing proteoglycans (PGs) with connected glycosaminoglycans (GAGs), in maintaining glomerular permselectivity. Primary human glomerular endothelial cells (HGEC) in culture were treated with the nephrosis-inducing agent puromycin aminonucleoside (PAN). Analysis was made by TaqMan real-time PCR, Western blot analysis, and by metabolic labeling with [35S]sulfate. The HGECs express several PGs: syndecan, versican, glypican, perlecan, decorin, and biglycan, which may contribute to the glomerular charge barrier. PAN treatment downregulated both the protein expression (by 25%) and the mRNA expression (by 37 ± 6%, P < 0.001, n = 8) of versican compared with control. Transferases important for chondroitin and heparan sulfate biosynthesis were also significantly downregulated by PAN, resulting in less sulfate groups, shorter GAG chains, and reduced PG net-negative charge. Moreover, analysis of the cell media after PAN treatment revealed a reduced content of [35S]sulfate-labeled PGs (40% of control). We conclude that PAN may cause proteinuria by affecting the endothelial cell-surface layer and not only by disrupting the foot process arrangement of the podocytes. Thus the endothelium may be a more important component of the glomerular barrier than hitherto acknowledged.
glomerular basal membrane; glycosaminoglycan; heparan sulfate; chondroitin sulfate; glycocalyx; nephrotic syndrome
This article has been cited by other articles:
![]() |
M. Jeansson, K. Bjorck, O. Tenstad, and B. Haraldsson Adriamycin Alters Glomerular Endothelium to Induce Proteinuria J. Am. Soc. Nephrol., January 1, 2009; 20(1): 114 - 122. [Full Text] [PDF] |
||||
![]() |
B. Haraldsson, J. Nystrom, and W. M. Deen Properties of the Glomerular Barrier and Mechanisms of Proteinuria Physiol Rev, April 1, 2008; 88(2): 451 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh, S. C. Satchell, C. R. Neal, E. A. McKenzie, J. E. Tooke, and P. W. Mathieson Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2885 - 2893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Andersson, U. Nilsson, C. Hjalmarsson, B. Haraldsson, and J. S. Nystrom Mild renal ischemia-reperfusion reduces charge and size selectivity of the glomerular barrier Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1802 - F1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bjornson Granqvist, K. Ebefors, M. A. Saleem, P. W. Mathieson, B. Haraldsson, and J. S. Nystrom Podocyte proteoglycan synthesis is involved in the development of nephrotic syndrome Am J Physiol Renal Physiol, October 1, 2006; 291(4): F722 - F730. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jeansson and B. Haraldsson Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier Am J Physiol Renal Physiol, January 1, 2006; 290(1): F111 - F116. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |